Chief Scientific Officer, Synthego Corporation
Rich Stoner is the Chief Scientific Officer at Synthego. Synthego’s mission is to turn biological research into an information science. At Synthego, Rich leads advanced research efforts in cell engineering, CRISPR bioinformatics, and clinical reagent design.
Prior to Synthego, Rich founded a digital pathology startup (WholeSlide), combining whole slide virtual microscopy with cloud and mobile technologies. During that time, Rich consulted for leading research institutions (Memorial Sloan Kettering Cancer Center, MIT, IBM, and many others) to build state-of-the art tools for neuroanatomy visualization, medical education, and melanoma classification.
Before moving to the startup world, Rich completed a postdoctoral fellowship at University of California, San Diego Neurosciences focused on neuroimaging- and gaze-based biomarker identification for the early diagnosis of autism spectrum disorders. He has published numerous articles across the field, including a paper in the New England Journal of Medicine describing patches of disorganization found in neocortex of children with autism.
Rich holds a PhD in neural engineering from the University of Pittsburgh.